YU43256B - Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one - Google Patents

Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one

Info

Publication number
YU43256B
YU43256B YU525/82A YU52582A YU43256B YU 43256 B YU43256 B YU 43256B YU 525/82 A YU525/82 A YU 525/82A YU 52582 A YU52582 A YU 52582A YU 43256 B YU43256 B YU 43256B
Authority
YU
Yugoslavia
Prior art keywords
piperazinylalkyl
phenoxyalkyl
subst
triazole
producing
Prior art date
Application number
YU525/82A
Other languages
English (en)
Other versions
YU52582A (en
Inventor
L Temple
Davis, Jr
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22922879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU43256(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU52582A publication Critical patent/YU52582A/xx
Publication of YU43256B publication Critical patent/YU43256B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU525/82A 1981-03-16 1982-03-11 Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one YU43256B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/244,464 US4338317A (en) 1981-03-16 1981-03-16 Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Publications (2)

Publication Number Publication Date
YU52582A YU52582A (en) 1985-06-30
YU43256B true YU43256B (en) 1989-06-30

Family

ID=22922879

Family Applications (1)

Application Number Title Priority Date Filing Date
YU525/82A YU43256B (en) 1981-03-16 1982-03-11 Process for producing subst.2-or 4-(phenoxyalkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one

Country Status (26)

Country Link
US (1) US4338317A (fr)
JP (1) JPS57159774A (fr)
KR (1) KR880001374B1 (fr)
AT (1) AT384022B (fr)
BE (1) BE892503A (fr)
CA (1) CA1198436A (fr)
CH (1) CH649539A5 (fr)
CY (1) CY1373A (fr)
DE (1) DE3209557A1 (fr)
DK (1) DK158728C (fr)
ES (1) ES8305756A1 (fr)
FI (1) FI73670C (fr)
FR (1) FR2501690B1 (fr)
GB (1) GB2096137B (fr)
GR (1) GR76076B (fr)
HK (1) HK4788A (fr)
IE (1) IE52788B1 (fr)
IT (1) IT1148137B (fr)
KE (1) KE3711A (fr)
LU (1) LU84011A1 (fr)
MX (1) MX9203176A (fr)
NL (2) NL190757C (fr)
SE (1) SE447256B (fr)
SG (1) SG30287G (fr)
YU (1) YU43256B (fr)
ZA (1) ZA821359B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
AT388555B (de) * 1983-06-29 1989-07-25 Bristol Myers Co Verfahren zur herstellung von neuen 1,2,4-triazol-3-on-derivaten
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1248531A (fr) * 1984-04-17 1989-01-10 Jeffrey C. Watkins Derives de substitution en 4 d'acides piperazine-2- carboxyliques
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2160423A1 (fr) * 1994-11-02 1996-05-03 Hemant N. Joshi Sels de nefazodone a taux de dissolution ameliores
EP0769297A1 (fr) 1995-10-17 1997-04-23 Bristol-Myers Squibb Company Utilisation de néfazodone pour la fabrication d'un médicament pour le traitement d'attaques de panique
CA2182241C (fr) * 1996-07-29 2002-09-17 Bo Lei Methodes pour la preparation de nefazodone
US5854248A (en) * 1996-07-31 1998-12-29 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
US5735873A (en) * 1996-12-19 1998-04-07 Maclean; David S. Surgical tool handle
US5917050A (en) * 1998-02-11 1999-06-29 Bayer Corporation Process for preparing alkoxytriazolinones
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
WO2000061128A2 (fr) * 1999-04-09 2000-10-19 Sepracor Inc. Hydroxy-nefazodone r
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US6465469B1 (en) 1999-04-09 2002-10-15 Sepracor Inc. S-hydroxynefazodone
CA2356450C (fr) 2001-09-10 2003-11-25 Brantford Chemicals Inc. Synthese amelioree de chlorhydrate de nefazodone
EP1513533B1 (fr) * 2002-05-24 2010-03-17 Carl-Fr. Coester Combinaison d'agents actifs pharmaceutiques et utilisation
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
EP1620401A4 (fr) * 2003-04-30 2008-08-13 Bayer Cropscience Ag Derives cycliques a substitution phenyle
DE602004028150D1 (de) * 2003-11-26 2010-08-26 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
WO2005102366A2 (fr) * 2004-04-19 2005-11-03 Philip Maxwell Satow Combinaisons de lithium et utilisations associees
TW200612961A (en) * 2004-05-18 2006-05-01 Fmc Corp Substituted cyclic urea derivatives
EP2317316A3 (fr) 2005-07-08 2011-06-15 Braincells, Inc. Procédés permettant d'identifier l'agent et les conditions qui modulent la neurogénèse
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (fr) 2005-10-31 2007-05-10 Braincells, Inc. Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (fr) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation de la neurogenèse par des ligands mélatoninergiques
EP2125017A2 (fr) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation de la neurogenèse en utilisant du modafinil
WO2009019472A1 (fr) * 2007-08-07 2009-02-12 Prosarix Limited Nouveaux modulateurs sérotonergiques
US9339500B2 (en) 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
TWI368512B (en) * 2009-04-30 2012-07-21 Univ Kaohsiung Medical Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
WO2012072665A1 (fr) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprenant de la pipampérone et des antagonistes/inhibiteurs de la recapture de la sérotonine
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione

Also Published As

Publication number Publication date
ES510449A0 (es) 1983-04-16
ZA821359B (en) 1983-01-26
US4338317A (en) 1982-07-06
FR2501690B1 (fr) 1985-07-05
AU8117082A (en) 1982-09-23
SE8201631L (sv) 1982-09-17
HK4788A (en) 1988-01-29
DK158728B (da) 1990-07-09
LU84011A1 (fr) 1983-02-22
IE820589L (en) 1982-09-16
CH649539A5 (de) 1985-05-31
IE52788B1 (en) 1988-03-02
JPH0237353B2 (fr) 1990-08-23
AT384022B (de) 1987-09-25
SE447256B (sv) 1986-11-03
NL8201021A (nl) 1982-10-18
CA1198436A (fr) 1985-12-24
ES8305756A1 (es) 1983-04-16
NL190757B (nl) 1994-03-01
DK112582A (da) 1982-09-17
DK158728C (da) 1990-12-03
FI820856L (fi) 1982-09-17
CY1373A (en) 1987-08-07
FI73670B (fi) 1987-07-31
IT8247978A0 (it) 1982-03-12
FI73670C (fi) 1987-11-09
KR830009089A (ko) 1983-12-17
AU555888B2 (en) 1986-10-16
KR880001374B1 (ko) 1988-07-29
GR76076B (fr) 1984-08-03
NL970014I1 (nl) 1997-06-02
NL970014I2 (nl) 1997-09-01
ATA104582A (de) 1987-02-15
GB2096137B (en) 1985-01-03
GB2096137A (en) 1982-10-13
DE3209557C2 (fr) 1993-07-15
NL190757C (nl) 1994-08-01
BE892503A (fr) 1982-09-15
MX9203176A (es) 1992-07-01
FR2501690A1 (fr) 1982-09-17
KE3711A (en) 1987-04-30
YU52582A (en) 1985-06-30
IT1148137B (it) 1986-11-26
DE3209557A1 (de) 1982-12-09
JPS57159774A (en) 1982-10-01
SG30287G (en) 1987-07-17

Similar Documents

Publication Publication Date Title
YU52582A (en) Process for producing subst.2-or 4-(phenoxylkyl-4)-or 2-piperazinylalkyl-1,2,4-triazole-3-one
PL239280A1 (en) Process for preparing novel 2,4-diamino-5-/substituted/-pyrimidines
YU227682A (en) Process for producing n-(4-(3-aminopropyl)-aminobutyl)-2-omega-guanidino-fatty acid-amindo)-2-subst.ethaneamide
YU199880A (en) Process for producing antiinflammaory 5-substituted 2,3-diaryl-thiophene
DE3263757D1 (en) Process for preparing 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriles
AU520715B2 (en) PROCESS FOR PRODUCING (d. 1)-5-METHYL-TETRAHYDROFOLIC ACID
YU214581A (en) Process for obtaining penicillanoyl-oxymethyl-1,1,1',1'-tetraoxide
YU100381A (en) Process for producing antiinflammatory 4,5-diaryl-alpha-(polyfluoralkyl)-1h-pyrrol-2-metamines
DE3272222D1 (en) Process for producing 4-hydroxy-2,4,6,-trimethylcyclohexa-2,5-diene-1-one
AU564581B2 (en) Process for making 1,2-dichloroethane
SU913942A3 (en) Process for producing 2,4-diamino-6-pyperidinopyrimidine-3-oxy (its modifications)
PT73016B (en) Process for preparing novel substituted pyrazinyl-1,2,4-oxidiazoles
YU155383A (en) Process for preparing 7,16-dioxa-2-aza-10-0-cladinosyl-12,0-desosaminyl-4,5-dihydroxy-6-ethy-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)hexadeca-1(2)-ene-8-one
IE800777L (en) Producing 4-(pyridyl-2-oxy)phenoxy-alkanecarboxylic acid¹derivatives.
AU528874B2 (en) A process for the preparation of 1,5-dimethylbicyclo (3.2.1) octanol-8
YU43628B (en) Process for producing 2- or 2,6-substituted penem compounds
JPS6450870A (en) Novel process for manufacturing 1,2,4-triazole-3-one
AU544794B2 (en) 4-(2,2-dialkyl-indane-1-ylidene)-piperidines
YU181084A (en) Process for making 1,1-dioxopenicilano-iloxim ethyl-6-(2-amino-2-phenylacetamido) penicilanate
DE3161383D1 (en) Process for the production of 2-alkenyl-1,1,2-trifluoro-2-halogenethyl ethers
DE3267778D1 (en) Process for producing 2,4-diamino-(3,5-dimethoxy-4-methoxy-ethoxy-benzyl)-pyrimidine
IT8121861V0 (it) Dispositivo di chiusura simultanea dei due vani di una pressa per laproduzione di pannelli truciolari o fibrosi di legno o suoi succedanei.
GB2015517B (en) Process for producing 3,5-dichloro- - methylstyrene
YU284181A (en) Process for obtaining 2,3-dihydro-pyrane
YU225981A (en) Process for obtaining pharmaceutically active 4-(2-hydroxy-4-(subst.)phenyl)naphthalene-2-one